new and important!

Dear colleagues,

We have updated the SIOPEL statutes to reflect the widening global participation into SIOPEL activities (linked below). I would encourage everyone to become members!

Membership has 2 categories. Members working in Europe are invited to become Full Members of the organisation.

This reflects the status that SIOPEL remains the “professional voice” for paediatric liver tumour activities within Europe. Other non-European regions have their own professional bodies e.g. COG, JPLT etc. to which they have responsibility to. Non-European Members (and European Members if they wish) can apply for Associate Membership.

In order for us to proceed I need to establish a formal membership list.

Dr. Bruce Morland,

It is important that everyone wishing to participate in SIOPEL activities completes the linked application form and returns it to me:


SIOPEL Membership application

SIOPEL Statutes


Virtual Consultation System to support Clinicians

We would like to encourage you to use a new open service of online consultations for your cases of pediatric liver tumors.

The platform allows for uploading radiology and pathology images and offers a coordinated advice from the top level experts representing three major international liver tumor study groups: Children Oncology Group (COG), Japanese Pediatric Liver Tumours Group (JPLT) and SIOPEL (International Childhood Liver Tumours Strategy Group).

Every new user has to register in the system before the first consultation request.

E-Learning area

We would like to inform that our E-Learning area is open and accessible by all health care providers (whether SIOPEL members or not) interested in the subject of pediatric liver tumors. In order to get access please send an email to using your institutional email address.


Childhood Liver Tumours Strategy Group - SIOPEL

The ultimate goal of the SIOPEL study group is to improve the prognosis and the quality of life of children affected by primary childhood liver tumors.

Primary hepatic tumours represent less than 1% of all childhood malignancies. Their frequency according to the different series is of about 0.8 - 1 case per million children less than 15 years of age per year. Hepatoblastoma (HB) is by far the commonest histological subtype of primary malignant hepatic tumours occurring in children less than 15 years of age, followed by hepatocellular carcinoma (HCC).

SIOPEL Group is composed of basic and clinical scientists coming from different European and Extra-European countries.